litlas
ログインアカウント作成

Willi Sauerbrei

1991–2025 年に発表

83
論文数
24,972
被引用数
52
h 指数
74
i10 指数

被引用数

Willi Sauerbrei の年別被引用数1988 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 7 件1994 年: 被引用 1 件1995 年: 被引用 11 件1996 年: 被引用 12 件1997 年: 被引用 15 件1998 年: 被引用 21 件1999 年: 被引用 49 件2000 年: 被引用 59 件2001 年: 被引用 68 件2002 年: 被引用 91 件2003 年: 被引用 109 件2004 年: 被引用 143 件2005 年: 被引用 177 件2006 年: 被引用 140 件2007 年: 被引用 176 件2008 年: 被引用 155 件2009 年: 被引用 205 件2010 年: 被引用 207 件2011 年: 被引用 254 件2012 年: 被引用 238 件2013 年: 被引用 237 件2014 年: 被引用 247 件2015 年: 被引用 241 件2016 年: 被引用 219 件2017 年: 被引用 195 件2018 年: 被引用 208 件2019 年: 被引用 598 件2020 年: 被引用 608 件2021 年: 被引用 646 件2022 年: 被引用 447 件2023 年: 被引用 338 件2024 年: 被引用 561 件2025 年: 被引用 265 件2026 年: 被引用 29 件1989〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,110 件、この内訳の 18.3%イギリス: 引用元論文 1,334 件、この内訳の 11.6%ドイツ: 引用元論文 828 件、この内訳の 7.2%中国: 引用元論文 790 件、この内訳の 6.8%カナダ: 引用元論文 677 件、この内訳の 5.9%オランダ: 引用元論文 609 件、この内訳の 5.3%イタリア: 引用元論文 498 件、この内訳の 4.3%フランス: 引用元論文 447 件、この内訳の 3.9%オーストラリア: 引用元論文 396 件、この内訳の 3.4%スイス: 引用元論文 317 件、この内訳の 2.7%スペイン: 引用元論文 286 件、この内訳の 2.5%ベルギー: 引用元論文 257 件、この内訳の 2.2%
0%18.3%その他 25.9%

機関

分野

  • Medicine58.2%
  • Biochemistry, Genetics and Molecular Biology18.8%
  • Mathematics5.3%
  • Computer Science4.3%
  • Decision Sciences2.3%
  • Immunology and Microbiology1.7%
  • その他9.4%

トピック

  • Breast Cancer Treatment Studies3%
  • Radiomics and Machine Learning in Medical Imaging1.9%
  • Statistical Methods and Inference1.8%
  • Cancer Immunotherapy and Biomarkers1.7%
  • Estrogen and related hormone effects1.3%
  • Cancer Genomics and Diagnostics1.1%
  • その他89.2%

共著者

全論文

検索で開く
  1. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses

    著者: Stefan Schandelmaier, Matthias Briel, Ravi Varadhan, Christopher H. Schmid, Niveditha Devasenapathy, Rodney A. Hayward, Joel Gagnier, Michael Borenstein, Geert J. M. G. van der Heijden, Issa J Dahabreh, Xin Sun, Willi Sauerbrei, Michael Walsh, John P. A. Ioannidis, Lehana Thabane, Gordon H. Guyatt - Canadian Medical Association Journal 2020 被引用: 717

  2. Assessment and comparison of prognostic classification schemes for survival data

    著者: Erika Graf, Claudia Schmoor, Willi Sauerbrei, M. Schumacher - Statistics in Medicine 1999 被引用: 904

  3. Dichotomizing continuous predictors in multiple regression: a bad idea

    著者: Patrick Royston, Douglas G. Altman, Willi Sauerbrei - Statistics in Medicine 2005 被引用: 2,228

  4. REporting recommendations for tumour MARKer prognostic studies (REMARK)

    著者: Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark - British Journal of Cancer 2005 被引用: 1,387

  5. Selection of important variables and determination of functional form for continuous predictors in multivariable model building

    著者: Willi Sauerbrei, Patrick Royston, Harald Binder - Statistics in Medicine 2007 被引用: 1,251

  6. A review of spline function procedures in R

    著者: Aris Perperoglou, Willi Sauerbrei, Michał Abrahamowicz, Matthias Schmid - BMC Medical Research Methodology 2019 被引用: 577

  7. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration

    著者: Willi Sauerbrei, Sheila E. Taube, Lisa M. McShane, Margaret M. Cavenagh, Douglas G. Altman - JNCI Journal of the National Cancer Institute 2018 被引用: 495

  8. Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges

    著者: Jörg Rahnenführer, Riccardo De Bin, Axel Benner, Federico Ambrogi, Lara Lusa, Anne‐Laure Boulesteix, Eugenia Migliavacca, Harald Binder, Stefan Michiels, Willi Sauerbrei, Lisa M. McShane, for topic group “High-dimensional data” (TG9) of the STRATOS initiative - BMC Medicine 2023 被引用: 88

  9. Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group.

    著者: Martin Schumacher, G. Bastert, Hans Bojar, K. Hübner, Manfred Olschewski, Willi Sauerbrei, Claudia Schmoor, C. Beyerle, R. L. A. Neumann, H. Rauschecker - Journal of Clinical Oncology 1994 被引用: 233

  10. Prognosis research strategy (PROGRESS) 4: Stratified medicine research

    著者: Aroon D. Hingorani, Daniëlle van der Windt, Richard D Riley, Keith R. Abrams, Karel Moons, Ewout W. Steyerberg, Sara Schroter, Willi Sauerbrei, Doug Altman, Harry Hemingway, for the PROGRESS Group - BMJ 2013 被引用: 517

  11. State of the art in selection of variables and functional forms in multivariable analysis—outstanding issues

    著者: for TG2 of the STRATOS initiative, Willi Sauerbrei, Aris Perperoglou, Matthias Schmid, Michał Abrahamowicz, Heiko Becher, Harald Binder, Daniela Dunkler, Frank E. Harrell, Patrick Royston, Georg Heinze - Diagnostic and Prognostic Research 2020 被引用: 249

  12. Facilitating harmonized data quality assessments. A data quality framework for observational health research data collections with software implementations in R

    著者: Carsten Oliver Schmidt, Stephan Struckmann, Cornelia Enzenbach, Achim Reineke, Jürgen Stausberg, Stefan Damerow, Marianne Huebner, Börge Schmidt, Willi Sauerbrei, Adrian Richter - BMC Medical Research Methodology 2021 被引用: 130

  13. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

    著者: Madeline Pe, Ahu Alanya, Ragnhild Sørum Falk, Cecilie Delphin Amdal, Kristin Bjordal, Jane Chang, Paul Cislo, Corneel Coens, Linda Dirven, Rebecca M. Speck, Kristina Fitzgerald, Jayne Galinsky, Johannes M. Giesinger, Bernhard Holzner, Saskia le Cessie, Daniel O’Connor, Kathy Oliver, Vivek Pawar, Chantal Quinten, Michael Schlichting, Jinma Ren, Satrajit Roychoudhury, Martin Taphoorn, Galina Velikova, Lisa M. Wintner, Ingolf Griebsch, Andrew Bottomley, Cat N. Bui, Nnadozie Emechebe, Rajesh Kamalakar, Elektra J. Papadopoulos, Kavita Sail, Rohini Sen, Sean Turner, Kim Cocks, Jaap C. Reijneveld, Christoph Gerlinger, Karen Keating, Yun Su, Birgit Wolf, Miaomiao Ge, Anders Ingelgaard, Barbara Peil, Maarten Voorhaar, Brendon Wong, Gracia Dekanic Arbanas, Karin Kuljanić, Duška Petranović, Ivana Rede, Juan Ignacio Arrarás, Stephen Joel Coons, Sonya Eremenco, Lindsey Murray, Bryce B. Reeve, Corinne S de Vries, Ralf Herold, Francesco Pignatti, Abigirl Machingura, Francesca Martinelli, Jammbe Musoro, Martine Piccart, Jorge Barriuso, Nathan I. Cherny, Urania Dafni, Elisabeth G.E. de Vries, Bishal Gyawali, Barbara Kiesewetter, Sjoukje F. Oosting, Felipe Roitberg, Gerhard Rumpold, Felix Schoepf, Michael Tschuggnall, Jennifer A. Black, Maxime Sasseville, Katherine M Soltys, Montserrat Ferrer, Olatz Garín, Gemma Vilagut, Christoph Schürmann, Stefanie M. Thomas, Beate Wieseler, Claire Snyder, Ariel Alonso Abad, Kris Bogaerts, Febe Brackx, Geert Molenberghs, Geert Verbeke, Cristián Frigolett Catalan, Jan Choi, Doranne Thomassen, Jan Geißler, Willi Sauerbrei, Franziska Gross, Micha J. Pilz, Yolanda Barbáchano, Lisa Campbell, Khadija Rantell, Gregoire Desplanques, Antoine Regnault, Kate Morgan ほか 41 名 - The Lancet Oncology 2023 被引用: 57

  14. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

    著者: Douglas G. Altman, Lisa M. McShane, Willi Sauerbrei, Sheila E. Taube - BMC Medicine 2012 被引用: 1,032

  15. Multivariable Model‐Building

    著者: Patrick Royston, Willi Sauerbrei - Wiley series in probability and statistics 2008 被引用: 709

  16. The use of fractional polynomials to model continuous risk variables in epidemiology

    著者: Patrick Royston, Gareth Ambler, Willi Sauerbrei - International Journal of Epidemiology 1999 被引用: 1,084

  17. Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors

    著者: D G Altman, Berthold Lausen, Willi Sauerbrei, Marc Schumacher - JNCI Journal of the National Cancer Institute 1994 被引用: 1,127

  18. A new measure of prognostic separation in survival data

    著者: Patrick Royston, Willi Sauerbrei - Statistics in Medicine 2004 被引用: 456

  19. Reporting recommendations for tumor marker prognostic studies (remark).

    著者: Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, G M Clark - Breast Cancer Research and Treatment 2005 被引用: 2,085

  20. A bootstrap resampling procedure for model building: Application to the cox regression model

    著者: Willi Sauerbrei, Martin Schumacher - Statistics in Medicine 1992 被引用: 599

  21. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials

    著者: Patrick Royston, Willi Sauerbrei - Statistics in Medicine 2004 被引用: 280

  22. Introduction to statistical simulations in health research

    著者: Anne‐Laure Boulesteix, Rolf H. H. Groenwold, Michał Abrahamowicz, Harald Binder, Matthias Briel, Roman Hornung, Tim P. Morris, Jörg Rahnenführer, Willi Sauerbrei - BMJ Open 2020 被引用: 70

  23. Structured reporting to improve transparency of analyses in prognostic marker studies

    著者: Willi Sauerbrei, Tim Haeussler, James Balmford, Marianne Huebner - BMC Medicine 2022 被引用: 28

  24. Reporting Recommendations for Tumor Marker Prognostic Studies

    著者: Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark - Journal of Clinical Oncology 2005 被引用: 775